We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$80.2B
AUM Growth
-$2.64B
Cap. Flow
-$1.24B
Cap. Flow %
-1.54%
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$955M
2
C icon
Citigroup
C
+$523M
3
NKTR icon
Nektar Therapeutics
NKTR
+$334M
4
SLB icon
SLB Ltd
SLB
+$292M
5
BABA icon
Alibaba
BABA
+$275M

Sector Composition

Rank Sector Weight
1 Financials 15.67%
2 Consumer Discretionary 14.85%
3 Healthcare 13.25%
4 Technology 13.05%
5 Energy 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
76
DELISTED
Celgene Corp
CELG
$273M 0.34%
3,064,194
-728,425
-19% -$69.9M
AVAL icon
77
Grupo Aval
AVAL
$5.67B
$273M 0.34%
32,841,460
-86,750
-0.3% -$762K
TGE
78
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$268M 0.33%
14,071,783
+1,761,140
+14% +$39.4M
BIIB icon
79
Biogen
BIIB
$29.9B
$261M 0.33%
952,411
-9,777
-1% -$3.03M
KMX icon
80
CarMax
KMX
$8.27B
$257M 0.32%
4,153,877
+298,982
+8% +$19.5M
NBIS
81
Nebius Group N.V.
NBIS
$47.7B
$256M 0.32%
6,497,369
+1,386,659
+27% +$54.4M
TIF
82
DELISTED
Tiffany & Co.
TIF
$255M 0.32%
2,614,100
-30,508
-1% -$3.15M
KHC icon
83
Kraft Heinz
KHC
$30.4B
$252M 0.31%
4,048,019
-868,002
-18% -$62.2M
SAGE
84
DELISTED
Sage Therapeutics
SAGE
$252M 0.31%
1,563,778
+84,247
+6% +$14.3M
BAC icon
85
Bank of America
BAC
$435B
$249M 0.31%
8,288,322
-1,092,984
-12% -$34.3M
ZTO icon
86
ZTO Express
ZTO
$18.2B
$247M 0.31%
16,444,697
+3,150,080
+24% +$49.4M
T icon
87
AT&T
T
$165B
$241M 0.3%
8,952,149
+906,581
+11% +$25.2M
WPZ
88
DELISTED
Williams Partners L.P.
WPZ
$239M 0.3%
6,941,928
-891,407
-11% -$34.8M
NOW icon
89
ServiceNow
NOW
$102B
$238M 0.3%
7,197,820
+5,763,115
+402% +$178M
NICE icon
90
Nice
NICE
$5.29B
$237M 0.3%
2,527,286
+182,340
+8% +$17M
MDLZ icon
91
Mondelez International
MDLZ
$77.7B
$237M 0.3%
5,680,014
-1,053,734
-16% -$45.8M
PCG icon
92
PG&E
PCG
$47.8B
$236M 0.29%
5,367,501
+120,566
+2% +$5.12M
EXAS
93
DELISTED
Exact Sciences
EXAS
$235M 0.29%
5,831,347
+2,910,506
+100% +$142M
ZBH icon
94
Zimmer Biomet
ZBH
$17.7B
$226M 0.28%
2,137,962
-585,972
-22% -$68M
EFX icon
95
Equifax
EFX
$20.3B
$224M 0.28%
1,904,468
-125,466
-6% -$15.1M
MAA icon
96
Mid-America Apartment Communities
MAA
$15.6B
$224M 0.28%
2,451,735
+584,929
+31% +$52.9M
DCP
97
DELISTED
DCP Midstream, LP
DCP
$221M 0.28%
6,291,452
-614,761
-9% -$23.4M
NWL icon
98
Newell Brands
NWL
$2.16B
$220M 0.27%
8,632,512
+3,422,160
+66% +$96.7M
OPLN
99
Openlane
OPLN
$4.17B
$219M 0.27%
10,674,393
-3,197
-0% -$64.5K
SNAP icon
100
Snap
SNAP
$7.32B
$217M 0.27%
13,688,542
+11,881,245
+657% +$193M

Similar funds

OppenheimerFunds's Q1 2018 Portfolio in Review

As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
  • OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
  • OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
  • OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
  • OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
  • OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
  • OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.